116 related articles for article (PubMed ID: 32061197)
1. Transgelin Silencing Induces Different Processes in Different Breast Cancer Cell Lines.
Dvorakova M; Lapcik P; Bouchalova P; Bouchal P
Proteomics; 2020 Apr; 20(7):e1900383. PubMed ID: 32061197
[TBL] [Abstract][Full Text] [Related]
2. Transgelins, cytoskeletal proteins implicated in different aspects of cancer development.
Dvorakova M; Nenutil R; Bouchal P
Expert Rev Proteomics; 2014 Apr; 11(2):149-65. PubMed ID: 24476357
[TBL] [Abstract][Full Text] [Related]
3. Loss of transgelin in breast and colon tumors and in RIE-1 cells by Ras deregulation of gene expression through Raf-independent pathways.
Shields JM; Rogers-Graham K; Der CJ
J Biol Chem; 2002 Mar; 277(12):9790-9. PubMed ID: 11773051
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of transgelin 2 promotes breast cancer metastasis by activating the reactive oxygen species/nuclear factor‑κB signaling pathway.
Yang L; Hong Q; Xu SG; Kuang XY; Di GH; Liu GY; Wu J; Shao ZM; Yu SJ
Mol Med Rep; 2019 Nov; 20(5):4045-4258. PubMed ID: 31485630
[TBL] [Abstract][Full Text] [Related]
5. Salvianolic acid A reverses the paclitaxel resistance and inhibits the migration and invasion abilities of human breast cancer cells by inactivating transgelin 2.
Zheng X; Chen S; Yang Q; Cai J; Zhang W; You H; Xing J; Dong Y
Cancer Biol Ther; 2015; 16(9):1407-14. PubMed ID: 26176734
[TBL] [Abstract][Full Text] [Related]
6. Transgelin is upregulated in stromal cells of lymph node positive breast cancer.
Dvořáková M; Jeřábková J; Procházková I; Lenčo J; Nenutil R; Bouchal P
J Proteomics; 2016 Jan; 132():103-11. PubMed ID: 26639304
[TBL] [Abstract][Full Text] [Related]
7. Paeonol reverses paclitaxel resistance in human breast cancer cells by regulating the expression of transgelin 2.
Cai J; Chen S; Zhang W; Hu S; Lu J; Xing J; Dong Y
Phytomedicine; 2014 Jun; 21(7):984-91. PubMed ID: 24680370
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells.
Aikins AR; Kim M; Raymundo B; Kim CW
Exp Biol Med (Maywood); 2017 Mar; 242(6):573-583. PubMed ID: 28058861
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of the proteins that are associated with the resistance to paclitaxel in human breast cancer cells.
Chen S; Dong Q; Hu S; Cai J; Zhang W; Sun J; Wang T; Xie J; He H; Xing J; Lu J; Dong Y
Mol Biosyst; 2014 Feb; 10(2):294-303. PubMed ID: 24292090
[TBL] [Abstract][Full Text] [Related]
10. Transgelin-2 expression in breast cancer and its relationships with clinicopathological features and patient outcome.
Hao R; Liu Y; Du Q; Liu L; Chen S; You H; Dong Y
Breast Cancer; 2019 Nov; 26(6):776-783. PubMed ID: 31144206
[TBL] [Abstract][Full Text] [Related]
11. Salvianolic acid A reverses paclitaxel resistance in human breast cancer MCF-7 cells via targeting the expression of transgelin 2 and attenuating PI3 K/Akt pathway.
Cai J; Chen S; Zhang W; Zheng X; Hu S; Pang C; Lu J; Xing J; Dong Y
Phytomedicine; 2014 Oct; 21(12):1725-32. PubMed ID: 25442283
[TBL] [Abstract][Full Text] [Related]
12. AKT and JNK Signaling Pathways Increase the Metastatic Potential of Colorectal Cancer Cells by Altering Transgelin Expression.
Zhou H; Zhang Y; Chen Q; Lin Y
Dig Dis Sci; 2016 Apr; 61(4):1091-7. PubMed ID: 26694173
[TBL] [Abstract][Full Text] [Related]
13. Transgelin increases metastatic potential of colorectal cancer cells in vivo and alters expression of genes involved in cell motility.
Zhou HM; Fang YY; Weinberger PM; Ding LL; Cowell JK; Hudson FZ; Ren M; Lee JR; Chen QK; Su H; Dynan WS; Lin Y
BMC Cancer; 2016 Feb; 16():55. PubMed ID: 26847345
[TBL] [Abstract][Full Text] [Related]
14. miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness.
Götte M; Mohr C; Koo CY; Stock C; Vaske AK; Viola M; Ibrahim SA; Peddibhotla S; Teng YH; Low JY; Ebnet K; Kiesel L; Yip GW
Oncogene; 2010 Dec; 29(50):6569-80. PubMed ID: 20818426
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of transgelin is an independent factor predictive of poor prognosis in patients with advanced pancreatic cancer.
Zhou L; Zhang R; Zhang L; Sun Y; Yao W; Zhao A; Li J; Yuan Y
Cancer Sci; 2013 Apr; 104(4):423-30. PubMed ID: 23331552
[TBL] [Abstract][Full Text] [Related]
16. Transgelin 2 Promotes Paclitaxel Resistance, Migration, and Invasion of Breast Cancer by Directly Interacting with PTEN and Activating PI3K/Akt/GSK-3β Pathway.
Liu L; Meng T; Zheng X; Liu Y; Hao R; Yan Y; Chen S; You H; Xing J; Dong Y
Mol Cancer Ther; 2019 Dec; 18(12):2457-2468. PubMed ID: 31488699
[TBL] [Abstract][Full Text] [Related]
17. Expression of the actin-associated protein transgelin (SM22) is decreased in prostate cancer.
Prasad PD; Stanton JA; Assinder SJ
Cell Tissue Res; 2010 Feb; 339(2):337-47. PubMed ID: 20012321
[TBL] [Abstract][Full Text] [Related]
18. Transgelin promotes migration and invasion of cancer stem cells.
Lee EK; Han GY; Park HW; Song YJ; Kim CW
J Proteome Res; 2010 Oct; 9(10):5108-17. PubMed ID: 20707403
[TBL] [Abstract][Full Text] [Related]
19. Transgelin: an actin-binding protein and tumour suppressor.
Assinder SJ; Stanton JA; Prasad PD
Int J Biochem Cell Biol; 2009 Mar; 41(3):482-6. PubMed ID: 18378184
[TBL] [Abstract][Full Text] [Related]
20. Association of the actin-binding protein transgelin with lymph node metastasis in human colorectal cancer.
Lin Y; Buckhaults PJ; Lee JR; Xiong H; Farrell C; Podolsky RH; Schade RR; Dynan WS
Neoplasia; 2009 Sep; 11(9):864-73. PubMed ID: 19724680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
